News

Microarray analyses cost as little as $100 per sample for standard gene-expression analysis and $300 per sample for more-complex analyses involving differentiation between variant splice forms, ...
Affymetrix, best known for its pioneering work in commercializing microarrays for gene expression research since the early 1990s, has grown to become much more than a microarray innovator. Through ...
The kit efficiently generates sufficient target from as little as 20 ng of FFPE-derived total RNA for complete gene expression profiling applications such as biomarker discovery and validation.
The FDA clears Affymetrix Gene Profiling Reagents as gene expression accessories to its GeneChip® Microarray Instrument System for IVD use, becomes fi ...
We report the first microarray-based gene expression profile study of neurothekeomas, nerve sheath myxomas, schwannomas and cellular fibrous histiocytomas.
The benchtop GeneAtlas platform has been developed as a complete microarray solution for measuring whole-genome expression, but at a price that will allow even small, cash-strapped labs to invest ...
Affymetrix, Inc. today announced that it has signed a distribution agreement with Fisher Scientific, Inc., part of Thermo Fisher Scientific, to distribute the GeneAtlas™ System and its related ...
The Microarray Innovations in Leukemia study assessed the clinical utility of gene expression profiling as a single test to subtype leukemias into conventional categories of myeloid and lymphoid ...
The assays do not require nucleic acid extraction or amplification, which streamlines customer workflows for applications including gene expression, copy number and cytogenetics.
SANTA CLARA, Calif.-- ( BUSINESS WIRE )--Affymetrix Inc. (Nasdaq:AFFX) today announced the launch of its 3 ’ IVT Express Kit, a faster and more reliable option for manual target preparation on ...
Affymetrix Inc. announced that the US Food and Drug Administration (FDA) has granted regulatory clearance to its GCS3000Dx (GCSDx) platform for in vitro gene expression diagnostic testing. The ...